Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C
Abstract Background Intravesical Mitomycin-C (MMC) following transurethral resection of bladder tumor (TURBT), while efficacious, is associated with side effects and poor utilization. Continuous saline bladder irrigation (CSBI) has been examined as an alternative. In this study we sought to compare...
Main Authors: | Andrew T. Lenis, Kian Asanad, Maher Blaibel, Nicholas M. Donin, Karim Chamie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12894-018-0408-6 |
Similar Items
-
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
by: Yu-Ching Wen, et al.
Published: (2021-01-01) -
Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study
by: Wei Phin Tan, et al.
Published: (2020-01-01) -
Intravesical Explosion Resulting in Bladder Rupture During Transurethral Resection of Bladder Tumors
by: Chih-Chiao Lee, et al.
Published: (2014-12-01) -
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
by: Stefanie Schmidt, et al.
Published: (2020-07-01) -
Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial
by: Rongxin Li, et al.
Published: (2020-07-01)